EHS
EHS

STAT+: Inside Pear’s ambitious plan to become the most dominant player in digital therapeutics



In the last six months, Pear Therapeutics has raised $100 million, inked a bevy of new deals, and launched a sweeping study of its app to treat substance use disorders.

It has also seen a high-profile study on its digital treatment for schizophrenia fail.

Continue to STAT+ to read the full story…

Source link

EHS
Back to top button